Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by persistent elevation in platelet count. It is a rare disorder in children, and children who have symptoms require treatment. We report the successful use of anagrelide, with few toxic effects, in the treatment of three children with ET. (J PEDIATR 1995; 127:495-8).
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health